-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2017 to Q4 2022.
- Aridis Pharmaceuticals, Inc. Costs and Expenses for the quarter ending December 31, 2022 was $8.63M, a 9.5% decline year-over-year.
- Aridis Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending December 31, 2022 was $33.1M, a 25.2% decline year-over-year.
- Aridis Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $33.1M, a 25.2% decline from 2021.
- Aridis Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $44.2M, a 89.1% increase from 2020.
- Aridis Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $23.4M, a 22.3% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)